Sbi Securities Co., Ltd. Vor Biopharma Inc. Transaction History

Sbi Securities Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$0.15 - $1.62 $40 - $432	267 Added 200.75%	400 $648,000
Q1 2025 May 01, 2025	SELL	$0.72 - $1.74 $250 - $605	-348 Reduced 72.35%	133 $95,000
Q4 2024 Feb 05, 2025	BUY	$0.64 - $1.27 $307 - $610	481 New	481 $534,000

872K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $383M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Sbi Securities Co., Ltd. with notifications on news.